Shandong Weigao repurchases shares, boosting treasury holdings

Shandong Weigao Group Medical Polymer Company Limited reported a share repurchase on September 8, 2025. The company bought back 472,800 H shares, which are now held as treasury shares. This transaction decreased the number of issued shares (excluding treasury shares) from 4,507,992,724 to 4,507,519,924. Concurrently, the number of treasury shares increased from 14,339,600 to 14,812,400.

The repurchase was executed on the Exchange at prices ranging from HK$5.61 to HK$5.69 per share, with an aggregate price paid of HK$2,666,008. The company's mandate to repurchase shares, granted on May 27, 2025, authorizes the buyback of up to 451,560,392 shares. To date, 8,164,000 shares have been repurchased on the Exchange, representing 1.808% of the issued shares (excluding treasury shares) as of the resolution date.

A moratorium period for any new share issues or sales/transfers of treasury shares is in effect until October 8, 2025. This repurchase aligns with the company's strategy under its existing mandate.